Sandmann S, Unger T L- and T-type calcium channel blockade - the efficacy of the calcium channel antagonist mibefradil Journal of Clinical and Basic Cardiology 1999; 2 (2): 187-201 PDF Summary Overview
| ||||||||||||||||||
Figure/Graphic 7: Kalziumkanal - Mibefradil Effects of verapamil (1 mg/kg i.v.) and mibefradil (3 mg/kg i.v.) on coronary blood flow (CBF) in dogs compared to placebo treated controls. CBF was measured with radioactive microspheres before and 10 min after initiation of drug treatment. Mean +/- SEM, * p<0.05 versus before therapy |
![]()
Figure/Graphic 7: Kalziumkanal - Mibefradil
Effects of verapamil (1 mg/kg i.v.) and mibefradil (3 mg/kg i.v.) on coronary blood flow (CBF) in dogs compared to placebo treated controls. CBF was measured with radioactive microspheres before and 10 min after initiation of drug treatment. Mean +/- SEM, * p<0.05 versus before therapy |